title: Prognosis of coma after therapeutic hypothermia: a prospective cohort study.
abstract: OBJECTIVE
  This study was designed to establish the reliability of neurologic examination, neuron-specific enolase (NSE), and median nerve somatosensory-evoked potentials (SEPs) to predict poor outcome in patients treated with mild hypothermia after cardiopulmonary resuscitation (CPR).
  
  
  METHODS
  This multicenter prospective cohort study included adult comatose patients admitted to the intensive care unit (ICU) after CPR and treated with hypothermia (32-34°C). False-positive rates (FPRs 1 - specificity) with their 95% confidence intervals (CIs) were calculated for pupillary light responses, corneal reflexes, and motor scores 72 hours after CPR; NSE levels at admission, 12 hours after reaching target temperature, and 36 hours and 48 hours after collapse; and SEPs during hypothermia and after rewarming. The primary outcome was poor outcome, defined as death, vegetative state, or severe disability (Glasgow Outcome Scale 1-3) after 6 months.
  
  
  RESULTS
  Of 391 patients included, 53% had a poor outcome. Absent pupillary light responses (FPR 1; 95% CI, 0-7) or absent corneal reflexes (FPR 4; 95% CI, 1-13) 72 hours after CPR, and absent SEPs during hypothermia (FPR 3; 95% CI, 1-7) and after rewarming (FPR 0; 95% CI, 0-18) were reliable predictors. Motor scores 72 hours after CPR (FPR 10; 95% CI, 6-16) and NSE levels were not.
  
  
  CONCLUSIONS
  In patients with persisting coma after CPR and therapeutic hypothermia, use of motor score or NSE, as recommended in current guidelines, could possibly lead to inappropriate withdrawal of treatment. Poor outcomes can reliably be predicted by testing brainstem reflexes 72 hours after CPR and performing SEP.
authors.affiliation: Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands. a.bouwes@amc.uva.nl
authors.forename: Aline
authors.initials: A
authors.lastname: Bouwes
authors.forename: Jan M
authors.initials: JM
authors.lastname: Binnekade
authors.forename: Michael A
authors.initials: MA
authors.lastname: Kuiper
authors.forename: Frank H
authors.initials: FH
authors.lastname: Bosch
authors.forename: Durk F
authors.initials: DF
authors.lastname: Zandstra
authors.forename: Arnoud C
authors.initials: AC
authors.lastname: Toornvliet
authors.forename: Hazra S
authors.initials: HS
authors.lastname: Biemond
authors.forename: Bas M
authors.initials: BM
authors.lastname: Kors
authors.forename: Johannes H T M
authors.initials: JH
authors.lastname: Koelman
authors.forename: Marcel M
authors.initials: MM
authors.lastname: Verbeek
authors.forename: Henry C
authors.initials: HC
authors.lastname: Weinstein
authors.forename: Albert
authors.initials: A
authors.lastname: Hijdra
authors.forename: Janneke
authors.initials: J
authors.lastname: Horn
mesh_terms: D000368:Aged; D016887:Cardiopulmonary Resuscitation / Q000379:methods / Q000706:statistics & numerical data*; D003128:Coma / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality*; D005073:Evoked Potentials, Somatosensory / Q000502:physiology*; D005260:Female; D015600:Glasgow Coma Scale; D023261:Glasgow Outcome Scale; D006801:Humans; D007036:Hypothermia, Induced / Q000009:adverse effects / Q000706:statistics & numerical data*; D008297:Male; D008475:Median Nerve / Q000503:physiopathology*; D008875:Middle Aged; D009460:Neurologic Examination / Q000706:statistics & numerical data; D010751:Phosphopyruvate Hydratase; D011379:Prognosis; D011446:Prospective Studies
chemical_list: D010751:Phosphopyruvate Hydratase